Related Experiment Videos
Nicotine and sympathetic neurotransmission
1Abteilung Innere Medizin III (Kardiologie, Angiologie und Pulmologie), Medical Clinic, University of Heidelberg, Germany.
Cardiovascular Drugs and Therapy
|January 1, 1997
Summary
Nicotine boosts heart rate and blood pressure by activating sympathetic nerves. Cardiac energy depletion sensitizes these nerves, increasing risks for heart attacks and arrhythmias, especially in patients with coronary artery disease.
Area of Science:
- Cardiovascular Pharmacology
- Neuroendocrinology
Background:
- Nicotine stimulates sympathetic neurotransmission, increasing heart rate, contractility, and blood pressure.
- Nicotine acetylcholine receptors (nAChRs) on sympathetic nerve endings and adrenal medulla mediate catecholamine release.
- nAChRs are ligand-gated cation channels crucial for ion flux and receptor activation.
Purpose of the Study:
- To investigate the effect of cardiac energy depletion on nicotine-induced catecholamine release.
- To elucidate the mechanisms underlying nicotine's cardiovascular effects, particularly in compromised hearts.
- To assess the potential clinical implications for cardiovascular events.
Main Methods:
- Utilized isolated perfused guinea-pig and human hearts under in vitro conditions.
- Examined concentration-response curves for nicotine-evoked norepinephrine release.
- Assessed effects of cardiac energy depletion on neurotransmitter release and tachyphylaxis.
Main Results:
- Cardiac energy depletion significantly sensitized cardiac sympathetic nerves to nicotine's norepinephrine-releasing effects.
- Observed potentiation of maximum transmitter release and delayed tachyphylaxis in depleted hearts.
- Nicotine-induced norepinephrine release increased cardiac oxygen demand and coronary resistance.
Conclusions:
- Cardiac energy depletion enhances nicotine's sympathetic nerve-activating effects.
- This sensitization may trigger acute cardiovascular events like myocardial infarction and arrhythmias in susceptible individuals.
- Understanding these mechanisms is critical for managing cardiovascular risk in patients exposed to nicotine, especially those with coronary artery disease.